Skip to content
10-Q

Quarterly Report

ATOSSA THERAPEUTICS, INC. ATOS

0001193125-25-276160

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 1, 2025 129.17M sh
Shares Diluted Q3 2025 · Sep 30, 2025 129.17M sh
Shares Diluted Q3 2025 · Sep 30, 2025 129.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 125.77M sh
Shares Diluted Q3 2025 · Sep 30, 2024 125.61M sh
Capex Q3 2025 · Sep 30, 2025 $16K
Capex Q3 2025 · Sep 30, 2024 $19K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$19.22M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$13.98M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $51.85M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $71.08M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $74.77M
Stockholders Equity Q3 2025 · Sep 30, 2025 $49.79M
Stockholders Equity Q3 2025 · Jun 30, 2025 $57.7M
Stockholders Equity Q3 2025 · Mar 31, 2025 $65.32M
Stockholders Equity Q3 2025 · Dec 31, 2024 $71.48M
Stockholders Equity Q3 2025 · Sep 30, 2024 $73.68M
Stockholders Equity Q3 2025 · Jun 30, 2024 $80.16M
Stockholders Equity Q3 2025 · Mar 31, 2024 $85.76M
Stockholders Equity Q3 2025 · Dec 31, 2023 $91.02M
Current Liabilities Q3 2025 · Sep 30, 2025 $8.23M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.97M
Total Liabilities Q3 2025 · Sep 30, 2025 $8.23M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.97M
Current Assets Q3 2025 · Sep 30, 2025 $55.68M
Current Assets Q3 2025 · Dec 31, 2024 $74.46M
Total Assets Q3 2025 · Sep 30, 2025 $58.01M
Total Assets Q3 2025 · Dec 31, 2024 $76.44M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.18
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.06
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.15
Eps Basic Q3 2025 · Sep 30, 2025 −$0.07
Eps Basic Q3 2025 · Sep 30, 2025 −$0.18
Eps Basic Q3 2025 · Sep 30, 2024 −$0.06
Eps Basic Q3 2025 · Sep 30, 2024 −$0.15
Sga Expense Q3 2025 · Sep 30, 2025 $3.88M
Sga Expense Q3 2025 · Sep 30, 2025 $10.68M
Sga Expense Q3 2025 · Sep 30, 2024 $2.97M
Sga Expense Q3 2025 · Sep 30, 2024 $9.76M
Rd Expense Q3 2025 · Sep 30, 2025 $5.37M
Rd Expense Q3 2025 · Sep 30, 2025 $15.03M
Rd Expense Q3 2025 · Sep 30, 2024 $3.41M
Rd Expense Q3 2025 · Sep 30, 2024 $10.71M
Net Income Q3 2025 · Sep 30, 2025 −$8.69M
Net Income Q3 2025 · Sep 30, 2025 −$23.83M
Net Income Q3 2025 · Jun 30, 2025 −$8.42M
Net Income Q3 2025 · Mar 31, 2025 −$6.72M
Net Income Q3 2025 · Sep 30, 2024 −$7.23M
Net Income Q3 2025 · Sep 30, 2024 −$19.16M
Net Income Q3 2025 · Jun 30, 2024 −$6.05M
Net Income Q3 2025 · Mar 31, 2024 −$5.88M
Operating Income Q3 2025 · Sep 30, 2025 −$9.25M
Operating Income Q3 2025 · Sep 30, 2025 −$25.71M
Operating Income Q3 2025 · Sep 30, 2024 −$6.39M
Operating Income Q3 2025 · Sep 30, 2024 −$20.47M